Abstract
Introduction: Diabetes is a global chronic pathology that has required a multidisciplinary approach, given that it is related to multiple pathologies, including cognitive deterioration, which is evident in older people. The purpose of this research was to carry out a prospective study to determine the prevalence between diabetes mellitus and cognitive deficit in a cohort of patients in an institution in northeastern Colombia. that, through the application of the MOCA test.
Methodology: A total of 170 participants, who met the inclusion criteria were administered the MOCA test (Montreal Cognitive Assessment) version 8,1 in Spanish, and complete paraclinical tests were requested. For statistical analysis, categorical variables were described with absolute frequencies and percentages, while continuous variables with measures of central tendency and dispersion, distribution was evaluated using the Shapiro-Wilk test. Likewise, for the bivariate analysis in continuous variables, chi square and Fisher's exact were used, while for continuous variables the Mann-Whitney U was used. Google Form was used for the questionnaire and the STATA 16 program was used for the statistical analysis.
Results: The results found in the MOCA test show statistically significant differences with age, with the degree of severe cognitive impairment being greater in patients over 50 years.
Discussion: Diabetes, as a multifactorial chronic metabolic pathology, is associated with cognitive impairment, with a statistically significant association in people over 50 years of age with a long history of DM2. Early screening and good metabolic control are important to minimize the cognitive and general health impact of this population.
Conclusions: Adequate glycemic control, maintaining an active mind and periodic control, especially in people over 50 years of age or in patients with long-term history, are aspects to be taken to avoid the appearance or rapid progression of cognitive disorders in the population with Diabetes.
References
Biessels GJ, Despa F. Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol. 2018;14(10):591-604. https://doi.org/10.1038/s41574-018-0048-7
Michailidis M, Moraitou D, Tata DA, Kalinderi K, Papamitsou T, Papaliagkas V. Alzheimer's disease as type 3 diabetes: common pathophysiological mechanisms between alzheimer's disease and type 2 diabetes. Int J Mol Sci. 2022;23(5):2687. https://doi.org/10.3390/ijms23052687
Matar-Khalil SR, Rubio-Sandoval FC. El deterioro cognitivo como una complicación de la diabetes mellitus tipo 2. Nova. 2021;19(37):25-41. https://doi.org/10.22490/24629448.5473
Selman A, Burns S, Reddy AP, Culberson J, Hemachandra Reddy P. The role of obesity and diabetes in dementia. Int J Mol Sci. 2022;23(16):9267. https://doi.org/10.3390/ijms23169267
Tinajero MG, Malik VS. An update on the epidemiology of type 2 diabetes: a global perspective. Endocrinol Metab Clin North Am. 2021;50(3):337-55. https://doi.org/10.1016/j.ecl.2021.05.013
Muñoz G, Degen C, Schröderb J, Toro P. Diabetes mellitus y su asociación con deterioro cognitivo y demencia. Rev Med Clin Condes. 2016;27(2):266-70. https://doi.org/10.1016/j.rmclc.2016.04.015
Jurado MB, Santibáñez R, Palacios-Mendoza M, Moreno-Zambrano D, Peñaherrera C, Duarte MC, et al. Deterioro cognitivo en pacientes diabéticos entre 55 a 65 años de edad. Reporte final de estudio observacional, transversal en la ciudad de Guayaquil. Rev Ecuat Neurol. 2018;27(1):41-50.
Singh DD, Shati AA, Alfaifi MY, Elbehairi SEI, Han I, Choi EH, et al. Development of dementia in type 2 diabetes patients: mechanisms of insulin resistance and antidiabetic drug development. Cells. 2022;11(23):3767. https://doi.org/10.3390/cells11233767
Xue M, Xu W, Ou YN, Cao XP, Tan MS, Tan L, et al. Diabetes mellitus and risks of cognitive impairment and dementia: a systematic review and meta-analysis of 144 prospective studies. Ageing Res Rev. 2019;55:100944. https://doi.org/10.1016/j.arr.2019.100944
Aguilar-Navarro SG, Mimenza-Alvarado AJ, Palacios-García AA, Samudio-Cruz A, Gutiérrez-Gutiérrez LA, Ávila-Funes JA. Validity and reliability of the spanish version of the montreal cognitive assessment (MOCA) for the detection of cognitive impairment in Mexico. Rev Colomb Psiquiatr. 2018;47(4):237-43. https://doi.org/10.1016/j.rcp.2017.05.003
Romo-Galindo DA, Padilla-Moya E. Utilidad de los test cognoscitivos breves para detectar la demencia en población mexicana. Arch Neruocien. 2020;23(4):26-34. https://doi.org/10.31157/an.v23i4.21
Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L. Diabetes mellitus and risk of dementia in the Kungsholmen project: a 6-year follow-up study. Neurology. 2004;63(7):1181-6. https://doi.org/10.1212/01.wnl.0000140291.86406.d1
Sugimoto T, Araki A, Fujita H, Fujita K, Honda K, Inagaki N, et al. Multidomain intervention trial for preventing cognitive decline among older adults with type 2 diabetes: J-MIND-Diabetes. J Prev Alzheimers Dis. 2024;11(6):1604-14. https://doi.org/10.14283/jpad.2024.117
Cheng G, Huang C, Deng H, Wang H. Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies. Intern Med J. 2012;42(5):484-91. https://doi.org/10.1111/j.1445-5994.2012.02758.x
Carbajal Díaz M, Rojas del Carpio C, Merino Taboada A, Díaz-Villegas G, Runzer Colmenares FM. Asociación entre trastornos neurocognitivos según MiniMental State examination y control glicémico en diabéticos mayores de 80 años. Rev Argent Endocrinol Metab. 2020;57(4):1-10.
Petermann F, Troncoso-Pantoja C, Martínez MA, Leiva AM, Ramírez-Campillo R, Poblete-Valderrama F, et al. Asociación entre diabetes mellitus tipo 2, historia familiar de diabetes y deterioro cognitivo en adultos mayores chilenos. Rev Med Chile. 2018;146(8):872-81. http://dx.doi.org/10.4067/s0034-98872018000800872
Mejía-Arango S, Zúñiga-Gil C. Diabetes mellitus como factor de riesgo de demencia en la población adulta mayor mexicana. Rev Neurol. 2011;53(7):397-405. https://doi.org/10.33588/rn.5307.2010628
Carvalho C, Moreira PI. Metabolic defects shared by Alzheimer's disease and diabetes: a focus on mitochondria. Curr Opin Neurobiol. 2023;79:102694. https://doi.org/10.1016/j.conb.2023.102694
W?troba M, Grabowska AD, Szukiewicz D. Effects of diabetes mellitus-related dysglycemia on the functions of blood-brain barrier and the risk of dementia. Int J Mol Sci. 2023;24(12):10069. https://doi.org/10.3390/ijms241210069
Ehtewish H, Arredouani A, El-Agnaf O. Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline. Int J Mol Sci. 2022 May 30;23(11):6144. https://doi.org/10.3390/ijms23116144
Bozanic A, Toro P, Bello-Lepe S, Hurtado-Oliva J, Beyle C, Valdés C, et al. Cognitive impairment with type 2 diabetes mellitus among community-dwelling older adults in Chile: prevalence, risk factors and cognitive characteristics. Front Hum Neurosci. 2023;16:1070611. https://doi.org/10.3389/fnhum.2022.1070611
Sajatovic M, Gunzler D, Einstadter D, Thomas C, McCormick R, Perzynski AT, et al. A preliminary analysis of individuals with serious mental illness and comorbid diabetes. Arch Psychiatr Nurs. 2016;30(2):226-9. https://doi.org/10.1016/j.apnu.2015.11.004
Mallorquí-Bagué N, Lozano-Madrid M, Toledo E, Corella D, Salas-Salvadó J, Cuenca-Royo A, et al. Type 2 diabetes and cognitive impairment in an older population with overweight or obesity and metabolic syndrome: baseline cross-sectional analysis of the PREDIMED-plus study. Sci Rep. 2018;8(1):16128. https://doi.org/10.1038/s41598-018-33843-8
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.